VoluMetrix’s NIVA|HF for Heart Failure Patients Designated as Breakthrough Device by U.S. FDA
VoluMetrix, a Nashville-based biotech startup dedicated to creating a new wave of solutions for vital monitoring to enhance well-being, today announced that its NIVAHF device has been designated